Telehealth developer InTouch Health said today it inked a multi-year licensing service agreement with Intuitive Surgical (NSDQ:ISRG) to deepen the robotic surgery giant’s Internet of Medical Things network connecting its da Vinci systems. Santa Barbara-based InTouch Health said that its proprietary IoMT network is intended to allow healthcare companies to connect their surgical systems globally to allow for real-time […]
Telehealth developer InTouch Health has raised $21 million in a new round of equity financing, according to an SEC filing posted this week. The company is not seeking any more funds in the round, and has not yet stated how it plans to spend the funds that it raised. Money in the round came from […]
InTouch Health said today it launched an expanded range of FDA Class II telehealth devices and software including dedicated tablets and software solutions to enable telehealth delivery. The Santa Barbara, Calif.-based company said the launch included the Vici Telehealth Cart, a customized Microsoft (NSDQ:MSFT) Surface Pro 4 tablet integrated into a slim form cart. InTouch also released […]
Schellhorn out, Emerson in as Monteris CEO Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year. Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year […]
InTouch Health said today that Intuitive Surgical (NSDQ:ISRG) picked up a stake for an undisclosed amount, as the companies embarked on a project to develop patient informatics solutions for Intuitive’s da Vinci robot-assisted surgery platform. Santa Barbara, Calif.-based InTouch said part of the investment will go toward enhancing its telehealth cloud to host and deliver 3D anatomical reconstructions for […]
The Indian government slashed reimbursement rates for drug-eluting stents by more than 61.5%, down to about $460 from roughly $1,200, aiming to give a boost to its domestic stents industry at the expense of the multinational players.
It’s the 2nd rate cut since October 2011, according to the Business Standard. India cut the rate of reimbursement for U.S.-made stents from 65,000 rupees (about $1,200) to 25,000 rupees (~$461), which is now the standard rate for stents regardless of origin, according to the newspaper.
Ocular Therapeutix said it closed a $23.8 million Series D extension round from existing backers for its sustained drug release technology to treat eye diseases.
The Bedford, Mass.-based medical device company said all of its current institutional investors ponied up for the round, including Polaris Ventures, Versant Ventures, SV Life Sciences, Sparta LLC, and Ascension Health Ventures.
Ocular Therapeutix is developing a punctum plug for the entry of the tear duct to release drug therapy to the surface of the eye over several months.
Santa Barbara, Calif.-based InTouch Health said it won FDA clearance for its RP-VITA, touting it as the first remote presence solution for acute patient care.
The RP-VITA allows doctors to take command of any clinical, patient or care team management process remotely, according a press release.